Photofrin photodynamic therapy for treatment of AIDS-related cutaneous Kaposi's sarcoma.

AIDS 1999 Sep;13(13):1697-704

Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York 14263, USA.

Objective: Kaposi's sarcoma, the most common malignancy in AIDS patients, often presents with painful cutaneous lesions that are difficult to treat effectively despite a wide variety of therapeutic approaches. We used photodynamic therapy in an attempt to provide effective palliative treatment for this disease.

Methods: Photodynamic therapy utilizes the activation by light of a photosensitizing drug that preferentially accumulates in tumor tissue such as Kaposi's sarcoma. We enrolled 25 patients who received 1.0 mg/kg of Photofrin 48 h before exposure to 100-400 J/cm2 of 630 nm light.

Results: Of the 348 lesions treated, 289 were evaluable: 32.5% had complete clinical response, 63.3% had partial clinical response and 4.2% were clinical failures. There was a strong correlation between response and light dose: 54% of lesions achieved a complete clinical response at optimum light dose (> 250 J/cm2). There was no correlation of response with CD4 cell count nor was there a change in CD4 cell count post-treatment. At 400 J/cm2 full field scabbing and necrosis occurred in 90% of the treated fields. Thus, the maximum tolerated dose was determined to be 300 J/cm2. At light doses of 250 J/cm2 and below the toxicities were limited to erythema and edema in the treatment field. Forty-three biopsies were taken 0.5 h to 4 months post-treatment. These showed little change in the B and T cell infiltrates identified. Kaposi's sarcoma cells disappeared post-treatment in certain lesions.

Conclusion: Photofrin is effective palliative treatment for HIV-associated Kaposi's sarcoma.

Download full-text PDF

Source
http://dx.doi.org/10.1097/00002030-199909100-00013DOI Listing
September 1999
2 Reads

Publication Analysis

Top Keywords

kaposi's sarcoma
20
photodynamic therapy
12
clinical response
12
effective palliative
8
palliative treatment
8
complete clinical
8
250 j/cm2
8
light dose
8
correlation response
8
cd4 cell
8
cell count
8
j/cm2
5
kaposi's
5
response
5
sarcoma
5
lesions achieved
4
54% lesions
4
dose 54%
4
achieved complete
4
response light
4

Altmetric Statistics

Similar Publications